Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 1/2013

01-01-2013 | Original Article

Homozygous missense mutation in BOLA3 causes multiple mitochondrial dysfunctions syndrome in two siblings

Authors: Tobias B. Haack, Boris Rolinski, Birgit Haberberger, Franz Zimmermann, Jessica Schum, Valentina Strecker, Elisabeth Graf, Uwe Athing, Thomas Hoppen, Ilka Wittig, Wolfgang Sperl, Peter Freisinger, Johannes A. Mayr, Tim M. Strom, Thomas Meitinger, Holger Prokisch

Published in: Journal of Inherited Metabolic Disease | Issue 1/2013

Login to get access

Abstract

Defects of mitochondrial oxidative phosphorylation constitute a clinical and genetic heterogeneous group of disorders affecting multiple organ systems at varying age. Biochemical analysis of biopsy material demonstrates isolated or combined deficiency of mitochondrial respiratory chain enzyme complexes. Co-occurrence of impaired activity of the pyruvate dehydrogenase complex has been rarely reported so far and is not yet fully understood. We investigated two siblings presenting with severe neonatal lactic acidosis, hypotonia, and intractable cardiomyopathy; both died within the first months of life. Muscle biopsy revealed a peculiar biochemical defect consisting of a combined deficiency of respiratory chain complexes I, II, and II+III accompanied by a defect of the pyruvate dehydrogenase complex. Joint exome analysis of both affected siblings uncovered a homozygous missense mutation in BOLA3. The causal role of the mutation was validated by lentiviral-mediated expression of the mitochondrial isoform of wildtype BOLA3 in patient fibroblasts, which lead to an increase of both residual enzyme activities and lipoic acid levels. Our results suggest that BOLA3 plays a crucial role in the biogenesis of iron-sulfur clusters necessary for proper function of respiratory chain and 2-oxoacid dehydrogenase complexes. We conclude that broad sequencing approaches combined with appropriate prioritization filters and experimental validation enable efficient molecular diagnosis and have the potential to discover new disease loci.
Appendix
Available only for authorised users
Literature
go back to reference Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J et al (2011) Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 3(65):65ra4PubMedCrossRef Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J et al (2011) Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 3(65):65ra4PubMedCrossRef
go back to reference Calvo SE, Compton AG, Hershman SG, Lim SC, Lieber DS, Tucker EJ et al (2012) Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med 4(118):118ra10PubMedCrossRef Calvo SE, Compton AG, Hershman SG, Lim SC, Lieber DS, Tucker EJ et al (2012) Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med 4(118):118ra10PubMedCrossRef
go back to reference Cameron JM, Janer A, Levandovskiy V, Mackay N, Rouault TA, Tong WH et al (2011a) Mutations in iron-sulfur cluster scaffold genes NFU1 and BOLA3 cause a fatal deficiency of multiple respiratory chain and 2-oxoacid dehydrogenase enzymes. Am J Hum Genet 89(4):486–495PubMedCrossRef Cameron JM, Janer A, Levandovskiy V, Mackay N, Rouault TA, Tong WH et al (2011a) Mutations in iron-sulfur cluster scaffold genes NFU1 and BOLA3 cause a fatal deficiency of multiple respiratory chain and 2-oxoacid dehydrogenase enzymes. Am J Hum Genet 89(4):486–495PubMedCrossRef
go back to reference Cameron JM, Levandovskiy V, Mackay N, Ackerley C, Chitayat D, Raiman J et al (2011b) Complex V TMEM70 deficiency results in mitochondrial nucleoid disorganization. Mitochondrion 11(1):191–199PubMedCrossRef Cameron JM, Levandovskiy V, Mackay N, Ackerley C, Chitayat D, Raiman J et al (2011b) Complex V TMEM70 deficiency results in mitochondrial nucleoid disorganization. Mitochondrion 11(1):191–199PubMedCrossRef
go back to reference Danhauser K, Iuso A, Haack TB, Freisinger P, Brockmann K, Mayr JA et al (2011) Cellular rescue-assay aids verification of causative DNA-variants in mitochondrial complex I deficiency. Mol Genet Metab 103(2):161–166PubMedCrossRef Danhauser K, Iuso A, Haack TB, Freisinger P, Brockmann K, Mayr JA et al (2011) Cellular rescue-assay aids verification of causative DNA-variants in mitochondrial complex I deficiency. Mol Genet Metab 103(2):161–166PubMedCrossRef
go back to reference De Praeter CM, Gerwig GJ, Bause E, Nuytinck LK, Vliegenthart JF, Breuer W et al (2000) A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. Am J Hum Genet 66(6):1744–1756PubMedCrossRef De Praeter CM, Gerwig GJ, Bause E, Nuytinck LK, Vliegenthart JF, Breuer W et al (2000) A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. Am J Hum Genet 66(6):1744–1756PubMedCrossRef
go back to reference Elstner M, Andreoli C, Klopstock T, Meitinger T, Prokisch H (2009) The mitochondrial proteome database: MitoP2. Methods Enzymol 457:3–20PubMedCrossRef Elstner M, Andreoli C, Klopstock T, Meitinger T, Prokisch H (2009) The mitochondrial proteome database: MitoP2. Methods Enzymol 457:3–20PubMedCrossRef
go back to reference Haack TB, Danhauser K, Haberberger B, Hoser J, Strecker V, Boehm D et al (2010) Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat Genet 42(12):1131–1134PubMedCrossRef Haack TB, Danhauser K, Haberberger B, Hoser J, Strecker V, Boehm D et al (2010) Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat Genet 42(12):1131–1134PubMedCrossRef
go back to reference Koyata H, Hiraga K (1991) The glycine cleavage system: structure of a cDNA encoding human H-protein, and partial characterization of its gene in patients with hyperglycinemias. Am J Hum Genet 48(2):351–361PubMed Koyata H, Hiraga K (1991) The glycine cleavage system: structure of a cDNA encoding human H-protein, and partial characterization of its gene in patients with hyperglycinemias. Am J Hum Genet 48(2):351–361PubMed
go back to reference Li H, Mapolelo DT, Dingra NN, Keller G, Riggs-Gelasco PJ, Winge DR et al (2010) Histidine 103 in Fra2 is an iron-sulfur cluster ligand in the [2Fe-2S] Fra2-Grx3 complex and is required for in vivo iron signaling in yeast. J Biol Chem 286(1):867–876PubMedCrossRef Li H, Mapolelo DT, Dingra NN, Keller G, Riggs-Gelasco PJ, Winge DR et al (2010) Histidine 103 in Fra2 is an iron-sulfur cluster ligand in the [2Fe-2S] Fra2-Grx3 complex and is required for in vivo iron signaling in yeast. J Biol Chem 286(1):867–876PubMedCrossRef
go back to reference Lissens W, De Meirleir L, Seneca S, Liebaers I, Brown GK, Brown RM et al (2000) Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum Mutat 15(3):209–219PubMedCrossRef Lissens W, De Meirleir L, Seneca S, Liebaers I, Brown GK, Brown RM et al (2000) Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum Mutat 15(3):209–219PubMedCrossRef
go back to reference Mayr JA, Freisinger P, Schlachter K, Rolinski B, Zimmermann FA, Scheffner T et al (2011a) Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway. Am J Hum Genet 89(6):806–812PubMedCrossRef Mayr JA, Freisinger P, Schlachter K, Rolinski B, Zimmermann FA, Scheffner T et al (2011a) Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway. Am J Hum Genet 89(6):806–812PubMedCrossRef
go back to reference Mayr JA, Zimmermann FA, Fauth C, Bergheim C, Meierhofer D, Radmayr D et al (2011b) Lipoic acid synthetase deficiency causes neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation. Am J Hum Genet 89(6):792–797PubMedCrossRef Mayr JA, Zimmermann FA, Fauth C, Bergheim C, Meierhofer D, Radmayr D et al (2011b) Lipoic acid synthetase deficiency causes neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation. Am J Hum Genet 89(6):792–797PubMedCrossRef
go back to reference Munnich A, Rustin P (2001) Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet 106(1):4–17, SpringPubMedCrossRef Munnich A, Rustin P (2001) Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet 106(1):4–17, SpringPubMedCrossRef
go back to reference Navarro-Sastre A, Tort F, Stehling O, Uzarska MA, Arranz JA, Del Toro M et al (2011) A fatal mitochondrial disease is associated with defective NFU1 function in the maturation of a subset of mitochondrial Fe-S proteins. Am J Hum Genet 89(5):656–667PubMedCrossRef Navarro-Sastre A, Tort F, Stehling O, Uzarska MA, Arranz JA, Del Toro M et al (2011) A fatal mitochondrial disease is associated with defective NFU1 function in the maturation of a subset of mitochondrial Fe-S proteins. Am J Hum Genet 89(5):656–667PubMedCrossRef
go back to reference Patel KP, O’Brien TW, Subramony SH, Shuster J, Stacpoole PW (2011) The spectrum of pyruvate dehydrogenase complex deficiency: Clinical, biochemical and genetic features in 371 patients. Mol Genet Metab Patel KP, O’Brien TW, Subramony SH, Shuster J, Stacpoole PW (2011) The spectrum of pyruvate dehydrogenase complex deficiency: Clinical, biochemical and genetic features in 371 patients. Mol Genet Metab
go back to reference Sasarman F, Antonicka H, Shoubridge EA (2008) The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2. Hum Mol Genet 17(23):3697–3707PubMedCrossRef Sasarman F, Antonicka H, Shoubridge EA (2008) The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2. Hum Mol Genet 17(23):3697–3707PubMedCrossRef
go back to reference Seyda A, Newbold RF, Hudson TJ, Verner A, MacKay N, Winter S et al (2001) A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13. Am J Hum Genet 68(2):386–396PubMedCrossRef Seyda A, Newbold RF, Hudson TJ, Verner A, MacKay N, Winter S et al (2001) A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13. Am J Hum Genet 68(2):386–396PubMedCrossRef
go back to reference Skladal D, Halliday J, Thorburn DR (2003) Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126(Pt 8):1905–1912PubMedCrossRef Skladal D, Halliday J, Thorburn DR (2003) Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126(Pt 8):1905–1912PubMedCrossRef
go back to reference Tucker EJ, Hershman SG, Kohrer C, Belcher-Timme CA, Patel J, Goldberger OA et al (2011) Mutations in MTFMT underlie a human disorder of formylation causing impaired mitochondrial translation. Cell Metab 14(3):428–434PubMedCrossRef Tucker EJ, Hershman SG, Kohrer C, Belcher-Timme CA, Patel J, Goldberger OA et al (2011) Mutations in MTFMT underlie a human disorder of formylation causing impaired mitochondrial translation. Cell Metab 14(3):428–434PubMedCrossRef
Metadata
Title
Homozygous missense mutation in BOLA3 causes multiple mitochondrial dysfunctions syndrome in two siblings
Authors
Tobias B. Haack
Boris Rolinski
Birgit Haberberger
Franz Zimmermann
Jessica Schum
Valentina Strecker
Elisabeth Graf
Uwe Athing
Thomas Hoppen
Ilka Wittig
Wolfgang Sperl
Peter Freisinger
Johannes A. Mayr
Tim M. Strom
Thomas Meitinger
Holger Prokisch
Publication date
01-01-2013
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 1/2013
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-012-9489-7

Other articles of this Issue 1/2013

Journal of Inherited Metabolic Disease 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine